Express Scripts Holding Co. (ESRX) Stake Cut by First Citizens Bank & Trust Co.

First Citizens Bank & Trust Co. decreased its position in shares of Express Scripts Holding Co. (NASDAQ:ESRX) by 6.4% during the second quarter, Holdings Channel reports. The firm owned 4,715 shares of the company’s stock after selling 324 shares during the period. First Citizens Bank & Trust Co.’s holdings in Express Scripts Holding were worth $357,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also recently bought and sold shares of the company. Waverton Investment Management Ltd bought a new position in Express Scripts Holding during the second quarter worth approximately $2,427,000. Weybosset Research & Management LLC boosted its position in Express Scripts Holding by 4.4% in the second quarter. Weybosset Research & Management LLC now owns 69,234 shares of the company’s stock worth $5,248,000 after buying an additional 2,925 shares during the last quarter. Quadrant Capital Group LLC boosted its position in Express Scripts Holding by 2.2% in the second quarter. Quadrant Capital Group LLC now owns 3,680 shares of the company’s stock worth $271,000 after buying an additional 80 shares during the last quarter. Lucas Capital Management boosted its position in Express Scripts Holding by 4.9% in the second quarter. Lucas Capital Management now owns 6,036 shares of the company’s stock worth $458,000 after buying an additional 280 shares during the last quarter. Finally, Savant Capital LLC bought a new position in Express Scripts Holding during the second quarter worth approximately $336,000. Institutional investors and hedge funds own 88.54% of the company’s stock.

Institutional Ownership by Quarter for Express Scripts Holding (NASDAQ:ESRX)

Shares of Express Scripts Holding Co. (NASDAQ:ESRX) traded up 1.57% during trading on Tuesday, reaching $70.31. 3,045,786 shares of the company traded hands. The company has a market capitalization of $44.31 billion, a price-to-earnings ratio of 17.37 and a beta of 1.16. The stock’s 50 day moving average is $70.78 and its 200 day moving average is $73.78. Express Scripts Holding Co. has a 1-year low of $65.55 and a 1-year high of $89.20.

Express Scripts Holding (NASDAQ:ESRX) last announced its quarterly earnings data on Monday, July 25th. The company reported $1.57 EPS for the quarter, hitting the Zacks’ consensus estimate of $1.57. Express Scripts Holding had a return on equity of 23.98% and a net margin of 2.64%. The business earned $25.20 billion during the quarter, compared to the consensus estimate of $25.42 billion. During the same period in the previous year, the company posted $1.44 earnings per share. The business’s revenue for the quarter was down .9% on a year-over-year basis. On average, analysts forecast that Express Scripts Holding Co. will post $6.36 EPS for the current year.

A number of research analysts have recently commented on the stock. Jefferies Group restated a “buy” rating on shares of Express Scripts Holding in a report on Monday, July 4th. Zacks Investment Research cut shares of Express Scripts Holding from a “buy” rating to a “hold” rating in a report on Thursday, August 4th. Mizuho upped their price target on shares of Express Scripts Holding from $77.00 to $82.00 and gave the stock a “neutral” rating in a report on Tuesday, August 2nd. Credit Suisse Group AG restated a “buy” rating on shares of Express Scripts Holding in a report on Monday, June 27th. Finally, Sanford C. Bernstein restated an “underperform” rating and issued a $68.00 price target on shares of Express Scripts Holding in a report on Tuesday, September 6th. Three investment analysts have rated the stock with a sell rating, ten have issued a hold rating and nine have issued a buy rating to the company. The stock currently has an average rating of “Hold” and an average price target of $81.53.

In other news, VP Christopher A. Mcginnis sold 1,785 shares of the business’s stock in a transaction dated Monday, September 12th. The stock was sold at an average price of $70.77, for a total transaction of $126,324.45. Following the completion of the transaction, the vice president now directly owns 4,955 shares of the company’s stock, valued at $350,665.35. The sale was disclosed in a filing with the SEC, which is accessible through this link. Also, Director Woodrow A. Myers, Jr. sold 12,036 shares of the business’s stock in a transaction dated Wednesday, September 14th. The stock was sold at an average price of $70.40, for a total value of $847,334.40. Following the transaction, the director now directly owns 14,918 shares of the company’s stock, valued at $1,050,227.20. The disclosure for this sale can be found here. Insiders own 0.54% of the company’s stock.

Express Scripts Holding Company Profile

Express Scripts, Inc is a pharmacy benefit management (PBM) company in North America, offering a range of services to its clients, which include health insurers, third-party administrators, employers, union-sponsored benefit plans, workers’ compensation plans and government health programs. It operates in two segments: PBM and Emerging Markets (EM).

5 Day Chart for NASDAQ:ESRX

Want to see what other hedge funds are holding ESRX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Express Scripts Holding Co. (NASDAQ:ESRX).

Receive News & Ratings for Express Scripts Holding Co. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Express Scripts Holding Co. and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

McDonald’s Keeping As Much As 25% in Hong Kong and China Stores
McDonald’s Keeping As Much As 25% in Hong Kong and China Stores
President Obama Take Steps to Block Chip Maker Acquisition by Chinese Company
President Obama Take Steps to Block Chip Maker Acquisition by Chinese Company
GoPro Planning to Cut 200 Jobs
GoPro Planning to Cut 200 Jobs
Early Data from Cyber Monday Shows Sales Increasing Over 9%
Early Data from Cyber Monday Shows Sales Increasing Over 9%
Retailers Anticipating Strong Support for Small Business Saturday
Retailers Anticipating Strong Support for Small Business Saturday
Eli Lilly Alzheimer’s Drug Does Not Pass the Test
Eli Lilly Alzheimer’s Drug Does Not Pass the Test


 
© 2006-2016 Ticker Report. Google+.